Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

Cuticapil Stem Hair Serum improves hair growth and reduces shedding when added to minoxidil.

Certain medications can cause gum problems, so patients and healthcare providers should be aware and monitor oral health.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Significant progress and investment in advanced therapies and regenerative medicine continue.

RNA modifications help heal wounds and could lead to new treatments.

AI improves aesthetic medicine but faces challenges like biases and privacy issues that need addressing for successful integration.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Monoclonal antibodies are often linked to alopecia areata cases.

The FDA approved a new Pfizer drug for hair loss in teens.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

The FDA rejected a testosterone drug again due to safety concerns.

Finasteride is most linked to drug-induced erectile dysfunction.

FDA-approved medications are important for treating high blood pressure in children, but non-approved ones can be used if needed.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.